UPDATE GIGS MEDIAUPDATE GIGS MEDIA
  • Home
  • Entertainment
  • Business & Finance
  • Education
    • Scholarships
  • Lifestyle
    • Health & Fitness
    • Travel
    • Dating & Relationships
    • Do it yourself
  • Tech
  • Privacy Policy
Facebook Twitter Instagram
Facebook Twitter Instagram
UPDATE GIGS MEDIAUPDATE GIGS MEDIA
CONTACT US
  • Home
  • Entertainment
  • Business & Finance
  • Education
    • Scholarships
  • Lifestyle
    • Health & Fitness
    • Travel
    • Dating & Relationships
    • Do it yourself
  • Tech
  • Privacy Policy
UPDATE GIGS MEDIAUPDATE GIGS MEDIA
Home » 54gene’s trouble came from a costly failed business bet
Tech

54gene’s trouble came from a costly failed business bet

adminBy adminOctober 31, 2022No Comments6 Mins Read
Facebook Twitter LinkedIn Telegram Pinterest Tumblr Reddit Email
54gene-Launches-7RiverLabs-2-scaled-1.jpeg
Share
Facebook Twitter LinkedIn Pinterest Email


It has been an eventful few months for 54gene, the Washington-based Nigerian genomic company. Barely two months after laying off 30% of its workforce, Dr Abasi Ene-Obong, its co-founder and CEO, stepped down as CEO, and Teresia Bost, its general counsel who joined the company September last year, stepped up as CEO. There was another round of layoffs in October; this time, 100 people, about 55% of its workforce, were laid off. According to three sources who spoke to TechCabal on condition of anonymity, the company has gone from over 300 staff to just 39 in three months. 

Recent reports and accounts from employees who spoke to us confirmed that the company is going through a tough time. One source shared that the company’s runway had almost dried up, and there was an urgent need for fresh capital to keep the lights on. This led to a down round that shrunk the company’s valuation to $50 million from the $170 million it got for its $25 million series B over 14 months ago. According to a recent report by TechCrunch, the down round closed at a 3x to 4x liquidation preference. Two of the sources mentioned to TechCabal that, this funding round and valuation haircut is likely why the CEO stepped down. Ene-Obong and 54gene didn’t respond to TechCabal’s inquiries for this story.

Get the best African tech newsletters in your inbox

Why the colossal valuation cut? 

For context, accepting such a funding term proves that the company is struggling and in need of rescuing cash. Here’s a timeline of how the company segued into such dire straits.

54gene was founded in 2019 by Dr Ene-Obong to research the molecular components of Africans and build a biogenetics data bank to enhance Africa-focused drug development and medical innovations. Even though Africans are more genetically diverse than people from other regions, only 2% of genetic research focuses on African subjects, while 90% focuses on Caucasian data. Hence the data diversity problems currently facing drug discovery and development globally. 54gene set out to solve this diversity problem by building a genetic data bank, starting with a sample of 100,000 Africans—mostly Nigerians.

For an emerging market where innovation mostly revolves around fintech, this company’s promises were novel: so novel that in July 2019, barely 7 months after launch, it got a $4.5 million seed funding from several high-profile investors including YCombinator, Fifty Years, Better Ventures, KdT Ventures, Hack VC and Techammer. 

Genomic research, the company’s focal business, demands lots of capital but takes a long time to yield any sizable income. Scientific research usually takes four to six years to complete and ship to pharmaceutical or other medical stakeholders. But a few months after closing the round, COVID-19 hit, and the company saw an opportunity to be a first-line responder to the pandemic in Nigeria. It quickly began to build resources around COVID testing, setting up a testing lab in Lagos and a mobile lab—a truck—in Ogun, and quickly became the first accredited private entity to administer COVID testing in Nigeria. It worked closely with the government, raised $500,000 in funding from corporate partners to ramp up testing, created supporting roles for the vertical, and hired lots of hands. 54gene generated substantial revenue from COVID-19, which could have served as a good funding alternative for its genomic operations, which was already expensive to run.

But COVID-19 revenue was ephemeral. By the end of 2021, it became obvious that the COVID business was not sustainable. So, the company launched another testing subsidiary called 7RL. This new business would offer healthcare providers and patients access to world-class, cost-effective, speedy, reliable and advanced molecular diagnostics. What could go wrong for a lab already running molecular research to start offering molecular diagnostics and advisory services? Answer: everything. 

Advertisements
Advertisements

According to one source, 7RL was the beginning of the business’ money woes. About three months before launching a new vertical, the company had raised its $25 million series B round and hired global pharmaceutical top talent, including Teresia Bost, its current CEO. There were enough resources to venture into this new business that was expected to provide cash flow as COVID-19 did. 7RL ran for  less than eight months before shutting down, but it hemorrhaged the most cash in the business, according to two sources. 

For context, one piece of biotech equipment could be as expensive as $1 million, and an executive at the company confirmed to TechCabal that there are a few such pieces of equipment in their labs. Sequencing is not cheap: it costs between $500 to $700 a pop. One human can generate a genome sequence of up to 1 terabyte of data, increasing the cost of the cloud storage used. A power shortage could render the sequence useless, regardless of its completion stage. So power must stay on, every time, leading to a mountainous cost of power operating in a country like Nigeria where power is unstable. 

7RL expanded into Kenya, setting up another world-class lab in Nairobi and hiring local scientists to man its operations—all of whom have been fired and the lab locked away completely. The combination of genetic research and diagnosis was going to deliver the world to 54gene, but for whatever reasons still unknown, it almost killed it instead. Despite all the investment put into it, 7RL didn’t deliver. This is surprising because the alarming rate of genetic and molecular diseases in the country should have given the company a soft-landing market. For instance, Nigeria is currently estimated to have 233,911 cancer cases, with 124,815 new cases and 78,899 cancer deaths, yearly. 

To stay afloat, the company said in a statement released on October 25 that it’s returning to a lean structure, shedding close to 90% of its employees. It has also taken a u-turn back to its core value proposition which is conducting genomic research and building biodata that would be used for precision medicine for Africans. 

“Going forward, the primary focus will be on the unique genomic research the company has started by further leveraging its genomic datasets derived from 54gene’s state-of-the-art biobank, that currently houses over 130,000 unique patient samples and corresponding genomic data, all with the objective of positioning the company to make contributions to precision medicine and drug discovery.,” the statement read. “This continues the meaningful work the company has invested in, whilst de-emphasising the clinical diagnostic business line at this time.”

Regardless of the runway refueling that came with the down round cash, and the change of guard at the helm, it might be too early to say the dark cloud is no more hovering over the company. Capital is as good as employees’ morale, especially when “current employees are anxious of being the next to be laid off,” one source told me. 

Conclusively, there are still questions begging for answers: How did 7RL, such a company with a massive market opportunity, fail at the back of substantial resources? But the chief among them is: what will become of the African genome company in the short and long term?

Get the best African tech newsletters in your inbox

More latest updates

  • 👨🏿‍🚀TechCabal Daily – Content moderators sue Meta in Kenya
    👨🏿‍🚀TechCabal Daily – Content moderators sue Meta in Kenya
    by admin●March 23, 2023
  • 🚀Entering Tech #24: Breaking down software engineering
    🚀Entering Tech #24: Breaking down software engineering
    by admin●March 22, 2023
  • How WomHub wants to facilitate female entrepreneurship in Cape Town
    How WomHub wants to facilitate female entrepreneurship in Cape Town
    by admin●March 22, 2023
  • Factor[e] launches $600,000 venture studio for Africa
    Factor[e] launches $600,000 venture studio for Africa
    by admin●March 22, 2023

Share this:

  • Tweet
Advertisements

Advertisements

Related

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
admin
  • Website

Related Posts

This South African school is using extended reality to facilitate learning

March 23, 2023

Court stops Meta and Sama from firing workers, more

March 23, 2023

Verod-Kepple Africa Ventures launches $43m fund for startups

March 23, 2023

You know the internet, how about extranet and intranet?

March 23, 2023

Atiku accuses INEC of reconfiguring BVAS to favour Tinubu

March 23, 2023

What state-generated electricity could mean for tech in Nigeria

March 23, 2023
Stay In Touch
  • Facebook
  • Twitter
  • Instagram
  • YouTube
Don't Miss
Tech

Has NFT found its biggest mainstream proponent yet in Africa?

By adminApril 13, 2022

The past few days have been good for NFT in Africa—Nigeria and Ghana, to be…

Share this:

  • Tweet

👨🏿‍🚀 TechCabal Daily – MTN is accelerating mobile money in Nigeria

April 13, 2022

Didi shuts down operations in South Africa

April 13, 2022

Back from the future: How embedded finance changed the world

April 13, 2022

Can Hytch succeed where GoMyWay failed?

April 13, 2022

More African central banks are considering digital currencies

April 13, 2022

This bootstrapped drone startup is promoting smart farming in Zimbabwe

April 13, 2022

The Next Wave: Africa does not know itself

April 13, 2022

TechCabal Daily – Kenya’s new law for content creators

April 14, 2022

INDUSTRY EXPERTS DISCUSS THE GROWTH AND FUTURE OF FINTECH IN NIGERIA AND INDIA IN SYMPOSIUM BY CLI COLLEGE, NIGERIA AND CHRIST UNIVERSITY, INDIA

April 14, 2022

28 days after launching investment arm, Luno crosses 10m user base

April 14, 2022

👨🏿‍🚀 TechCabal Daily – The war for Twitter

April 15, 2022

Digital Nomads: Julian Owusu’s journey from football to fintech

April 15, 2022

In the wake of explosive accusations against Africa’s most valuable startup, Flutterwave co-founder speaks

April 16, 2022
Advertise with us
update gigs advert images
LATEST

This South African school is using extended reality to facilitate learning

March 23, 2023

Court stops Meta and Sama from firing workers, more

March 23, 2023

Verod-Kepple Africa Ventures launches $43m fund for startups

March 23, 2023
About Us
About Us

We are dedicated to bringing you news from around the world that is entertaining, educative, informative and self inspiring.. Your source for the lifestyle news.

We're accepting new partnerships right now.

Email Us: updatemedia050@gmail.com

Subscribe to Updates

Get the latest news from Update Gigs Media about entertainment, sports, lifestyle, art, design and business.

Facebook Twitter Instagram
© 2023 Designed by Ntechy Digital System.

Type above and press Enter to search. Press Esc to cancel.